US 8092796
Monoclonal antibodies against ANGPTL4
granted A61KA61K2039/505A61P
Quick answer
US patent 8092796 (Monoclonal antibodies against ANGPTL4) held by LEXICON PHARMACEUTICALS, INC. expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- LEXICON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61P, A61P3/00, A61P3/04